Index -
P/E -
EPS (ttm) -0.35
Insider Own 31.80%
Shs Outstand 159.85M
Perf Week 8.04%
Market Cap 2.81B
Forward P/E 33.69
EPS next Y 0.52
Insider Trans -0.07%
Shs Float 109.02M
Perf Month 4.32%
Income -55.36M
PEG -
EPS next Q 0.10
Inst Own 69.31%
Short Float 5.24%
Perf Quarter 6.28%
Sales 354.34M
P/S 7.94
EPS this Y 1.00%
Inst Trans -1.86%
Short Ratio 10.88
Perf Half Y 44.46%
Book/sh 6.55
P/B 2.69
EPS next Y 20.36%
ROA -3.53%
Short Interest 5.71M
Perf Year -24.84%
Cash/sh 1.47
P/C 11.98
EPS next 5Y 33.70%
ROE -5.21%
52W Range 11.81 - 24.61
Perf YTD 0.11%
Dividend Est. -
P/FCF 34.76
EPS past 5Y -10.50%
ROI -4.12%
52W High -28.43%
Beta 1.60
Dividend TTM -
Quick Ratio 2.62
Sales past 5Y 16.90%
Gross Margin 47.35%
52W Low 49.11%
ATR (14) 0.65
Dividend Ex-Date -
Current Ratio 2.62
EPS Y/Y TTM -471.37%
Oper. Margin 3.97%
RSI (14) 54.45
Volatility 3.67% 3.72%
Employees 1391
Debt/Eq 0.28
Sales Y/Y TTM 5.57%
Profit Margin -15.62%
Recom 2.45
Target Price 19.72
Option/Short Yes / Yes
LT Debt/Eq 0.28
EPS Q/Q -235.59%
Payout -
Rel Volume 0.82
Prev Close 17.30
Sales Surprise 1.53%
EPS Surprise -17.81%
Sales Q/Q 1.59%
Earnings May 07 AMC
Avg Volume 525.25K
Price 17.61
SMA20 2.02%
SMA50 -0.24%
SMA200 8.55%
Trades
Volume 431,175
Change 1.79%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-10-24 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$23
Apr-04-24 Initiated
JMP Securities
Mkt Perform
Feb-26-24 Initiated
Leerink Partners
Market Perform
$19
Dec-07-23 Initiated
UBS
Neutral
$17
Dec-05-23 Initiated
KeyBanc Capital Markets
Sector Weight
Aug-22-23 Downgrade
Jefferies
Buy → Hold
$24.50 → $17
Aug-10-23 Downgrade
William Blair
Outperform → Mkt Perform
Apr-12-23 Initiated
Stephens
Overweight
$28
Apr-03-23 Downgrade
Barclays
Overweight → Equal Weight
$25
Dec-14-22 Downgrade
Robert W. Baird
Outperform → Neutral
$17 → $19
Sep-08-22 Initiated
Berenberg
Buy
$23
Aug-25-22 Initiated
Credit Suisse
Outperform
$22
Jul-01-22 Initiated
Piper Sandler
Overweight
$28
Jan-11-22 Upgrade
Jefferies
Hold → Buy
$31
Aug-05-21 Resumed
Credit Suisse
Neutral
$36
Jul-23-21 Initiated
Robert W. Baird
Outperform
$30
Mar-03-21 Initiated
Barclays
Overweight
$40
Jan-06-21 Initiated
Morgan Stanley
Equal-Weight
$35
Jan-05-21 Initiated
William Blair
Outperform
Jan-05-21 Initiated
Jefferies
Hold
$33
Show Previous Ratings
Apr-16-24 08:00AM
Apr-09-24 04:15PM
Apr-04-24 07:01PM
Mar-02-24 08:41AM
Mar-01-24 07:10AM
(Thomson Reuters StreetEvents) +8.41%
06:05PM
Loading…
Feb-29-24 06:05PM
04:52PM
04:10PM
Feb-01-24 04:30PM
Jan-31-24 11:03PM
Dec-13-23 04:30PM
Nov-21-23 04:30PM
Nov-10-23 01:22PM
Nov-09-23 10:41AM
(Thomson Reuters StreetEvents)
Nov-08-23 07:15PM
04:10PM
Loading…
04:10PM
Oct-31-23 12:00PM
Oct-20-23 08:34AM
Oct-11-23 04:15PM
Sep-19-23 08:15AM
Sep-13-23 05:01AM
Aug-29-23 04:15PM
08:15AM
Aug-23-23 01:43PM
Aug-22-23 02:41AM
Aug-12-23 08:07AM
Aug-11-23 06:09AM
Aug-10-23 09:41AM
(Thomson Reuters StreetEvents) -7.65%
Aug-09-23 04:15PM
Aug-03-23 09:00PM
08:55AM
Loading…
Aug-02-23 08:55AM
Jul-27-23 09:47AM
Jul-13-23 04:30PM
Jun-02-23 04:15PM
May-16-23 06:50AM
May-09-23 06:53AM
(Thomson Reuters StreetEvents) -10.72%
May-08-23 06:35PM
04:15PM
May-02-23 10:02AM
04:24AM
May-01-23 02:03PM
10:01AM
07:13AM
Apr-28-23 07:15AM
Apr-27-23 08:00AM
Apr-10-23 04:30PM
Apr-06-23 12:19PM
Apr-05-23 12:25PM
11:42AM
Apr-04-23 12:43PM
Mar-29-23 12:01PM
Mar-28-23 03:00PM
Mar-27-23 11:35AM
Mar-15-23 05:41PM
10:00AM
Mar-14-23 09:40AM
Mar-09-23 12:20PM
08:00AM
Mar-08-23 07:04AM
Mar-07-23 08:00AM
Mar-02-23 07:43AM
(Thomson Reuters StreetEvents) +17.30%
Mar-01-23 06:25PM
04:16PM
04:15PM
Feb-27-23 04:30PM
Feb-01-23 04:30PM
Jan-09-23 11:40AM
Jan-04-23 07:31AM
Dec-23-22 06:35PM
Dec-08-22 04:30PM
Nov-26-22 09:01PM
Nov-11-22 04:28PM
Nov-07-22 07:05PM
04:15PM
08:00AM
Nov-02-22 05:00PM
Oct-19-22 08:00AM
Oct-13-22 07:45AM
Aug-31-22 08:00AM
Aug-11-22 04:38PM
Aug-09-22 09:00PM
07:45PM
05:00PM
(Thomson Reuters StreetEvents)
04:15PM
Aug-05-22 08:00AM
Aug-01-22 03:02PM
Jul-28-22 08:00AM
Jul-25-22 08:00AM
Jul-13-22 08:00AM
Jul-12-22 08:00AM
Jul-09-22 02:05PM
Jun-28-22 08:00AM
Jun-21-22 08:00AM
May-05-22 09:31PM
06:55PM
04:15PM
May-03-22 04:30PM
Apr-20-22 08:00AM
Mar-24-22 09:29AM
Mar-17-22 09:36AM
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Princeton, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS Apr 02 '24 Sale 16.85 14,427 243,161 50,091 Apr 04 04:45 PM Traynor Richard M. SVP AND GENERAL COUNSEL Apr 01 '24 Option Exercise 0.00 13,295 0 178,800 Apr 03 05:08 PM SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS Apr 01 '24 Option Exercise 0.00 16,498 0 67,208 Apr 03 05:07 PM SHERMAN NICOLETTE D CHIEF HUMAN RESOURCES OFFICER Apr 01 '24 Option Exercise 0.00 8,219 0 25,684 Apr 03 05:05 PM Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF Apr 01 '24 Option Exercise 0.00 16,498 0 152,840 Apr 03 05:03 PM Gallagher John E CHIEF FINANCIAL OFFICER Apr 01 '24 Option Exercise 0.00 27,295 0 22,545 Apr 03 05:02 PM Aspbury Robert PRESIDENT; SCIENTIFIC SOFTWARE Apr 01 '24 Option Exercise 0.00 16,498 0 293,867 Apr 03 05:00 PM Feehery William F CHIEF EXECUTIVE OFFICER Apr 01 '24 Option Exercise 0.00 69,799 0 2,263,269 Apr 03 04:44 PM Traynor Richard M. SVP AND GENERAL COUNSEL Apr 01 '24 Sale 18.00 3,000 54,000 173,524 Apr 03 05:08 PM Traynor Richard M. SVP AND GENERAL COUNSEL Mar 04 '24 Sale 18.28 3,000 54,840 162,368 Mar 05 04:45 PM SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS Feb 20 '24 Sale 18.00 5,000 90,000 54,975 Feb 21 04:40 PM Traynor Richard M. SVP AND GENERAL COUNSEL Feb 12 '24 Sale 18.00 6,000 108,000 165,368 Feb 14 04:33 PM Traynor Richard M. SVP AND GENERAL COUNSEL Dec 26 '23 Sale 18.00 6,000 108,000 171,368 Dec 27 06:36 PM Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF Sep 11 '23 Sale 14.60 51,224 747,870 128,883 Sep 12 04:26 PM BROSHY ERAN Director Aug 22 '23 Buy 15.80 4,807 75,951 14,360 Aug 23 04:38 PM BROSHY ERAN Director Aug 21 '23 Buy 16.10 193 3,107 9,553 Aug 23 04:38 PM SMITH PATRICK F PRESIDENT, INTEGRATED DRUG DEV Jun 05 '23 Sale 21.55 19,104 411,691 59,975 Jun 06 04:56 PM BROSHY ERAN Director May 23 '23 Option Exercise 0.00 9,360 0 9,360 May 25 08:50 AM Crane Rosemary A Director May 23 '23 Option Exercise 0.00 9,324 0 9,324 May 25 08:45 AM CASHMAN JAMES E III Director May 17 '23 Option Exercise 0.00 9,067 0 447,849 May 18 04:35 PM Killefer Nancy Director May 17 '23 Option Exercise 0.00 9,067 0 15,498 May 18 04:47 PM WALSH MATTHEW M Director May 17 '23 Option Exercise 0.00 9,067 0 176,968 May 19 08:36 AM Collins Cynthia Director May 17 '23 Option Exercise 0.00 9,067 0 15,498 May 19 08:34 AM Traynor Richard M. SVP AND GENERAL COUNSEL May 11 '23 Sale 20.82 5,000 104,100 177,368 May 15 04:41 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite